$16.780
-0.800 (-4.77%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCAX por análisis de gráficos similares
Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.80 (+0.09%). The 1-week path is $16.86 (+0.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Bicara Therapeutics Inc?
Bicara Therapeutics Inc is currently not a strong buy due to its recent performance and financial losses, despite a potential upside reflected in analyst price targets. The current price is $17.50, with a forward P/E of 0, indicating no earnings expected in the near term. The RSI is at 38.166, suggesting the stock is nearing oversold territory, but the company reported a net loss of $56.2 million in Q1 2026, which raises concerns about its financial health. While analysts have set price targets as high as $39, the significant losses and management changes create uncertainty, warranting a hold recommendation for now.
BCAX cerró en $16.78 el Friday, tras bajar -4.77%
Bicara Therapeutics Inc (BCAX) last closed at $16.78, losing -4.77%. These facts feed the 1-day and 1-week BCAX price prediction above.
Factores de la previsión
Los factores de la previsión de Bicara Therapeutics Inc (BCAX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCAX, ordenadas por similitud.
Análisis de estacionalidad de BCAX
Historically the probability of a positive October return for BCAX is 58.62%. September offers the highest probability of a positive month at 59.26%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCAX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $10.67 | $11.92 | $14.31 | -28.96% |
| Nov 2026 | $7.57 | $9.92 | $10.55 | -40.91% |
| Dec 2026 | $10.44 | $12.80 | $14.55 | -23.72% |
En 2026, se proyecta que Bicara Therapeutics Inc (BCAX) oscile entre $7.57 y $14.55.
Previsión mensual de Bicara Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Bicara Therapeutics Inc promedie $11.92, con un mínimo de $10.67 y un máximo de $14.31.
En Nov de 2026, se proyecta que Bicara Therapeutics Inc promedie $9.92, con un mínimo de $7.57 y un máximo de $10.55.
En Dec de 2026, se proyecta que Bicara Therapeutics Inc promedie $12.80, con un mínimo de $10.44 y un máximo de $14.55.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.